An abnormal stimulation of the cAMP pathway has been recognized as the primary event in various pathological situations that lead to goitrogenesis or thyroid tumors. Thyroid adenomas are monoclonal neoplasms that become independent of thyroid stimulating hormone (TSH) in their secretory function and growth. Mutated forms of the TSH receptor (TSHR) and the adenylyl cyclase-activating Gsa protein, which confer a constitutive activity on these proteins, have been observed in human adenomas. The FRTL-5 rat thyroid cell line is a permanent but untransformed line; the growth of which depends on the presence of TSH, and at least in part, on the stimulation of the cAMP pathway. In order to compare the oncogenic potential of the activated mutant Gsa protein and the constitutively activated TSHR, we have transfected FRTL-5 cells with an expression vector bearing either the cDNA of the Gsa gene carrying the A201S mutation or the cDNA of the TSH receptor carrying the M453T mutation recently identi®ed in a case of congenital hyperthyroidism. The expression of these two cDNAs was driven by the bovine thyroglobulin gene promoter. We show that, although the expression of both the Gsa or TSHR mutant proteins leads to TSHindependent proliferation and to constitutive cAMP accumulation in FRTL-5 cells, only the mutant TSHR is able to induce neoplastic transformation, as demonstrated by growth in semi-solid medium and tumorigenesis in nude mice.
Introduction
The development and progression of thyroid tumors are associated with mutations of speci®c genes involved in growth control. The growth and dierentiation of the thyroid gland are, at least in part, controlled by thyroid stimulating hormone (TSH) which activates, via its receptor (TSHR) and an adenylyl cyclaseactivating Gs protein, the cAMP pathway. Mutations in genes of this pathway are often observed in thyroid tumors independent of TSH in their secretory function and growth. Mutations in the TSHR gene have been observed in human adenomas (Russo et al., 1995a; Paschke et al., 1994; Parma et al., 1993) and in congenital hyperthyroidism (Duprez et al., 1994; Kopp et al., 1995; De Roux et al., 1996; Tonacchera et al., 1996) . These mutated TSHR permanently activate adenylyl cyclase; some of them also activate the phosphatidylinositide pathway . Mutations aecting the adenylyl cyclase-activating protein Gsa subunit have been engineered which constitutively activate it (Freissmuth and Gilman, 1989) . The biochemical phenotype associated with these mutations is the inhibition of the intrinsic GTPase activity which maintains the protein in the active GTP-bound form and leads to an elevated hormone-independent adenylyl cyclase activity (Zachary et al., 1990) . Natural mutations conferring a constitutive Gsa activation were ®rst identi®ed by Landis et al. (1989) in growth hormone-secreting human pituitary adenomas. These mutations aect codon 201 or 227 and the mutated protein is named Gsp. Identical mutations have been later identi®ed in thyroid adenomas (Lyons et al., 1990; Russo et al., 1995b) and in malignant dierentiated thyroid cancers (Suarez et al., 1991; Goretzi et al., 1992) , in agreement with their possible participation in thyroid oncogenesis.
The FRTL-5 rat thyroid cell line is a permanent but untransformed line that expresses several traits of the thyroid dierentiation (Ambesi-Impiombato et al., 1980) . Consequently, it has been widely used as an in vitro model for the thyroid follicular cell. The growth of FRTL-5 cells depends on the presence of TSH, and, at least in part, on the stimulation of the cAMP pathway. It has been demonstrated that transfection in FRTL-5 cells of the Gsp cDNA carrying the Q227L mutation is sucient to induce TSH-independent proliferation (Muca and Vallar, 1994) . In addition, the expression of this protein carrying the A201S mutation in transgenic mice thyrocytes induces hyperfonctioning adenomas after a long latency (8 months) (Michiels et al., 1994) . In a parallel model, the expression of the adenosine receptor A2 induces a massive stimulation of the cAMP cascade and leads to hyperplasia and a dramatic hyperthyroidism (Ledent et al., 1992) . Considering that both transgenes are expected to stimulate proliferation and dierentiation through the same pathway, this phenotypic dierence is striking.
In order to assess the oncogenic potential of the mutated TSHR and to compare it with the oncogenic potential of a Gsp protein we have transfected FRTL-5 cells with an expression vector bearing either the cDNA of the Gsp gene carrying the A201S mutation, or the cDNA of the TSHR carrying the M453T, mutation recently identi®ed in a case of congenital hyperthyroidism (De Roux et al., 1996) . This mutant TSHR induces a constitutive activation of the cAMP cascade when expressed in COS-7 cells. We show that, although the expression of either the Gsp or the TSHR mutant protein leads to TSH-independent proliferation and to constitutive cAMP accumulation in FRTL-5 cells, only the mutant TSHR is able to induce neoplastic transformation, as demonstrated by growth in semi solid medium and tumorigenesis in nude mice.
Results
FRTL-5 is an immortal cell line established from normal rat thyrocytes (Ambesi-Impiombato et al., 1980) . It displays the characteristics of the tissue from which it originates in that both the proliferation and the expression of a thyrocyte-speci®c dierentiation program are strictly dependent on the presence of TSH.
FRTL-5 cells were grown in medium containing 5% calf serum supplemented with a cocktail of six hormones including TSH (Ambesi-Impiombato et al., 1980) . When TSH is removed from this medium, the cells enter a quiescent state without loosing their viability for several weeks.
Selection of TSH-independent FRTL-5
It has been reported that expression of a mutant Gsa subunit (Q227L) correlates with the capacity of FRTL-5 to grow in TSH-free medium (Muca and Vallar, 1994) . In these experiments, FRTL-5 cells that have been infected with a retrovirus carrying the Q227L Gsa mutant cDNA under the control of a LTR promoter, were submitted to neomycine resistance selection. This selection yields cell clones which grow in the absence of TSH. We have explored the possibility of using a straightforward selection for clones the growth of which has become independent on the presence of TSH, upon transfection with either the (R201H) Gsp or the mutant TSHR* driven by the thyrocyte-speci®c promoter of the thyroglobulin gene (Ledent et al., 1990) . This direct selection avoids the variability in phenotypes expected from the clones selected through neomycine resistance and allows an accurate comparison of the respective eciency of Gsp and TSHR* in bringing about TSH independence. Table 1 shows the comparative capacity of Gsp and TSHR* to yield TSH independence in FRTL-5 cells. It demonstrates ®rst that the growth of FRTL-5 cells is strictly dependent upon TSH since no clone was observed when untransfected cells were maintained in TSH-free medium. Second, the transfection of the wild type form of either Gsa or TSHR did not lead to TSH-independent growth of FRTL-5. By contrast, the transfection of Gsp or TSHR*, in the same conditions, gave rise to cells capable of overgrowing the monolayer of resting cells. It is worth pointing out that in these selection conditions, the two transgenes display the same eciency in bringing about TSH-independent cell growth.
Phenotype of TSH-independent FRTL-5 clones
Two cell lines derived from clones selected from FRTL-5 transfected with either Gsp (cl1 and 3c) or mutant TSHR* (cl3 and 5) were submitted to detailed phenotypic characterization.
Expression of transfected genes
The presence of transgene-speci®c mRNAs was investigated by RT ± PCR assay. The results are presented in Figure 1 . Transgene-speci®c transcripts were identi®ed in both series of clones by reference to the products ampli®ed from the original plasmid vector carrying the respective transgenes. The speci®city of these signals is demonstrated by their absence from untransfected cells. Expression of the mutant form of the human TSHR has also been detected by immunocytochemistry with a monoclonal antibody raised against the human TSHR (T3-495) (Loosfelt et al., 1992 ) (data not shown).
Growth capacity
The growth capacity of cells from each clone estimated by measuring doubling time in TSH-free medium, are presented in Table 2 . By reference to FRTL-5 cells which display a doubling time of 19 h that is strictly dependent on the presence of TSH, Gsp-expressing clones, in the absence of TSH, display a doubling time (26 h and 24 h) slightly longer than the TSHR*-derived clones (20 h). Therefore, although the expression of either of these two mutated genes did substitute at least in part for exposure to TSH in terms of cloning eciency, only the TSHR* gene induced a doubling time close to the doubling time of FRTL-5 cells exposed to TSH.
cAMP level
The permanent expression of Gsp or TSHR* is expected to constitutively activate the adenylyl cyclase, leading to an elevated steady state level of cAMP. This possibility was investigated in the two types of clones by measuring the cAMP content in growing cells and comparing with the cAMP level induced by TSH exposure of TSH-deprived FRTL-5 cells. The results are presented in Figure 2 which shows that expression of TSHR* led to a cAMP level comparable to that induced by TSH on FRTL-5 (206 fold increase over the basal level in TSH deprived cells). A slightly lower level of cAMP was induced by Gsp; nevertheless this level was tenfold higher than the FRTL-5 basal level.
Oncogenic transformation
The oncogenic potential of mutations aecting the cAMP pathway in thyroid tissue is suggested by multiple observations of somatic mutations in Gsa and TSHR genes in human thyroid tumors. This oncogenic potential was further illustrated by the occurrence of thyroid adenoma in transgenic mice in which the cAMP pathway was disturbed by the expression of Gsp (Michiels et al., 1994) or of the adenosine A2 receptor (Ledent et al., 1992) . We were interested in investigating the possibility that this oncogenic potential could be demonstrable in FRTL-5-derived cells expressing mutant forms of Gsa or TSHR. The transformed phenotype of these cells was measured by two dierent assays: capacity to grow in semi-solid medium (anchorage independence) and tumorigenicity in nude mice.
Anchorage-independent growth The anchorage-independent growth of the TSH-independent clones was measured as their capacity to grow in soft agar. The results presented in Figure 3 show that, in contrast to the Gsp clones which had a limited growth capacity in these conditions (cloning eciency: 3.65% and 0.65%), the TSHR* clones display a distinct cloning eciency (28.8% and 17.7%). It should be noted that, contrary to a previous report (Fusco et al., 1982) , our original FRTL-5 cells displayed a limited capacity to grow in agar in 6H-containing medium (cloning eciency: 6.6%).
Tumorigenicity in nude mice 2610 6 cells were injected in nude mice. Tumor growth was scored 6 weeks after injection. The results presented in Table 3 , show that the expression of the mutant TSHR* confers tumorigenicity in nude mice to FRTL-5 cells. By contrast, the expression of Gsp does not lead to this phenotypic property.
Discussion
The aim of the experiments reported here was to investigate the oncogenic potential of genetic events that lead to a deregulation of the cAMP pathway and are frequently observed in thyroid tumors. We have used two genes that are involved in the pathway of cAMP activation at dierent levels: the TSH receptor gene and the adenylyl cyclase-stimulating Gsa subunit gene.
The expression of both transgenes used in these experiments was driven by the thyroglobulin promoter which is speci®cally activated in dierentiated thyrocytes. As mentioned in the Materials and methods section, insulin, which has been shown to activate transcription from the thyroglobulin promoter in FRTL-5 (Santisteban et al., 1987; Saji et al., 1994) was included in both 5H and 6H media. Transfection of vectors, expressing the mutant form of Gsa (Gsp) or of the TSHR (TSHR*), brings about the capacity of FRTL-5 to grow in the absence of exogenous stimulation by TSH. Thus, stable TSH-independent Cells were seeded at a density of 5610 4 cells per 2 cm diameter plates. Cells were harvested by trypsinization at 24 h intervals for 4 days and the number of viable cells determined after trypan blue coloration. Doubling time was calculated from the exponential part of the curve. Data are representative of two experiments each performed in duplicate clones which have retained, at least, part of their speci®c dierentiation program, as witnessed by the activity of the Tg promoter, have been readily selected. However, only these cells which expressed the mutant TSHR* had acquired a transformed phenotype as estimated by the capacity to grow in semi-solid medium and to induce tumors in nude mice.
FRTL-5 is an immortal cell line which is not tumorigenic in euthyroid nude mice. They become tumorigenic when circulating TSH is arti®cially elevated after chemical destruction of the thyroid gland (Ossendorp et al., 1990) or after goitrogenic drug administration (Peter et al., 1991) . Thus the tumorigenicity of the TSHR*-clones in euthyroid nude mice was expected.
Tumorigenic clones derived from FRTL-5 cells following transfection with a vector carrying the wildtype human TSHR cDNA have been previously described (Derwahl et al., 1992) ; however in this report, the authors failed to detect any expression of the transfected cDNA in the transformed clones, therefore raising question about the role played by the wild-type human TSH receptor in the acquisition of the tumorigenic phenotype. It should be emphasized, that under the conditions used in our experiments, no TSH-independent clones could be selected following transfection with wild-type human TSHR cDNA.
The isolation of stable FRTL-5 transfectants expressing various genes carrying mutations that activate the cAMP pathway, have been previously reported. In these reports, the b2-adrenergic receptor (Hen et al., 1989; Tsuzaki et al., 1991) the cholera toxin A1 subunit (Saji et al., 1994) or the mutant Q227L Gsp (Muca and Vallar, 1994) have been used. Our study diers from these reports since we have directly selected for TSH-independent growth, brought about by expression of the transduced-gene, whereas in the studies cited above, the selection was based on neomycine resistance gene expression.
Both Hen et al. (1989) and Tsuzaki et al. (1991) have shown that b2-adrenergic receptor-expressing FRTL-5 cells responded to the agonist isoproterenol by accumulating cAMP. These cells also became able to grow in the presence of isoproterenol and in the absence of TSH, even though TSH remained a better inducer of growth (Hen et al., 1989 In agreement with our own results, (Muca and Vallar, 1994) have obtained Q227L Gsp-expressing FRTL-5 cells which were able to proliferate in the absence of TSH, but which displayed a reduced growth rate as compared to TSH-stimulated FRTL-5 cells. Again these authors have not examined the transformation state of their Q227L Gsp-expressing cells. On the contrary, using two cholera toxin A1 subunit-expressing FRTL-5 clones described by Saji et al. (1994) Zeiger et al. (1996) , have observed both proliferation in the absence of TSH and tumorigenicity in nude mice. To the extent that cholera toxin A1 subunit exclusively operates through ADP-ribosylation of the Gsa subunit, they conclude that the activation of Gsa and the resulting increased intracellular cAMP can induce neoplastic transformation of FRTL-5 cells. The dierence in tumorigenic phenotype that we have observed between TSHR* and Gsp-expressing FRTL-5 clones could be due exclusively to the dierence in cAMP accumulation displayed by the two types of clones examined. In spite of this possible interpretation of our results, which would be in keeping with the usually accepted role of cAMP in stimulating both the function and the proliferation of thyrocytes, we would like to suggest two dierent hypotheses, the testing of which is likely to open new avenues of investigation.
According to the ®rst hypothesis, and in agreement with the demonstration that the human TSHR can couple with similar potencies to dierent G proteins (Laugwitz et al., 1996) , one could expect that TSHR* could activate more than one signal transduction pathway, when Gsp activates only one. However, it is unlikely that, in the case of the TSHR mutant form we have used, polyphosphoinositide hydrolysis by a PLC b isoform could contribute to signal transduction, because the M453T TSHR* expressed in COS-7 cells was showed to stimulate adenylyl cyclase but not PLC b isoform activity (De Roux et al., 1996) . Moreover, Laglia et al. (Laglia et al., 1996) have shown that an increase in cAMP level inhibits G protein-coupled activation of PLC in FRTL-5 cells.
The second hypothesis suggests that when Gsp only is expressed in cells which are known to produce endogenous Gs timers, Gsp does activate the adenylyl cyclase isoforms present in the cell, but no dissociation of endogenous Gsa and Gbg occurs. On the contrary, when TSHR is activated through ligand binding or mutation or when the Gsa subunit is ADP-ribosylated, Gbg dimers are liberated. It is now well established that the bg dimers can play a role in signaling, either in contributing together with Gsa, to the stimulation of isoforms II and IV of adenylyl cyclase or in regulating the activities of phospholipase C (PLC) b isoforms, of phosphatidylinositol 3-kinase (PI3-K) IB isoform (reviewed in Birnbaumer et al., 1990; Housley and Milligan, 1997; Vanhaesebroeck et al., 1997) or of MAP-kinases (Van Biesen et al., 1995) .
P13-K activity certainly deserves further investigations. As a matter of fact, preliminary experiments, using the LY 294002 speci®c inhibitor of P13-K (Vlahos et al., 1994) , have shown a complete inhibition of soft agar growth of Tg-TSHR* clones 3 and 5 at doses which did not aect the rate of growth on plastic plates (our preliminary experiments).
Materials and methods

Cell culture
FRTL-5 rat thyroid cells were grown as described (Ambesi-Impiombato et al., 1980) . The 6H culture medium consisted of Coon's modi®ed Ham's F12 medium (Sigma) containing 5% of donnor calf serum (Gibco), penicilline, 100 U/ml, streptomycine, 100 mg/ml and the six hormones: insulin (Sigma) 10 mg/ml, hydrocortiscone (Sigma) 10 nM, transferrin (Sigma) 5 mg/ml, liver cell growth factor (Calbiochem) 10 ng/ml, somatostatin (Calbiochem) 10 ng/ml and bovine TSH (Sigma) 10 mU/ ml. FRTL-5-derived clones were cultured in TSH-free medium (5H).
Expression vectors
The vector expressing the R201H mutant form (Gsp) of the Chinese hamster Gsa subunit under the control of the bovine thyroglobulin promoter has been described (Michiels et al., 1994) . Three new vectors were constructed from the backbone of this vector (Tg plasmid) by the substitution to Gsp cDNA of: (i) The wild type Chinese hamster Gsa cDNA, (ii) The wild type human TSHR cDNA, (iii) The M453T mutant human TSHR* cDNA.
Transfection and establishment of stable cell lines 10 6 FRTL-5 cells plated in 5 cm diameter plates in 6H medium were transfected the next day with 10 mg of plasmid, by the calcium phosphate transfection technique (Wigler et al., 1978) . In some cases, transfected cells were submitted to hypertonic shock for 30 s at room temperature by exposure to 15% glycerol in HeBS (140 mM NaCl, 5 mM KCl, 0.75 mM Na 2 HPO 4 .2H 2 O, 6 mM dextrose, 25 mM HEPES). Two days later, the 6H medium was replaced by 5H medium and changed twice a week for 3 weeks. Clones overgrowing from the quiescent FRTL-5 cell layer were isolated with cylinders and cloned by end point dilution.
Transgene expression
Gsp and TSHR* mRNA expression was monitored by RT ± PCR. Polyadenylated RNAs were extracted from 26 10 5 cells (Quick-prep Micro mRNA puri®cation kit, Pharmacia) and reverse transcribed by Moloney murine leukemia virus reverse transcriptase for 60 min at 378C using random hexadeoxynucleotides (®rst strand cDNA synthesis kit, Pharmacia). A sequence speci®c for the transgene Tg-Gsp or Tg-TSHR* was ampli®ed from the resulting cDNA by 30 cycles of PCR with a Taq DNA polymerase (Promega). Ampli®cation included an initial denaturation step for 5 min at 918C, followed by 30 cycles (1 min at 918C, 1 min at 508C, 1 min at 728C) and 5 min at 728C. Ampli®ed products were analysed by electrophoresis on a 2% agarose gel. Two sets of primer were used: (i) A primer speci®c for the transcribed untranslated region of the Tg plasmid, OliTransg (CACAGAAGTAAGGTT-CCTTCAC) that is present in the two plasmids Tg-Gsp and Tg-TSHR and (ii) two primers speci®c for each respective coding sequence: OliGs (GAGTTTCTGA-GAATCAGCACTG) and OliTSHR (GACGCTCAACA-TAGTTGCCT). The ampli®cation of an actin speci®c sequence served as a reference for RNA load (Weigel et al., 1993) . The three ampli®cations were performed separately. TSHR* expression was also assessed by immunocytochemistry using a monoclonal antibody directed against the Cterminal region of human TSHR (T3-495 IgG1 antibody) (Loosfelt et al., 1992) and revealed with a polyclonal goat antimouse IgG (Amersham NA 931) coupled to peroxidase (DAB Sigma fast).
Measurement of intracellular cAMP accumulation
In these experiments cells were seeded in 12-well plates at a density of 2610 5 , 10 5 or 4610 4 cells/well in the case of FRTL-5, Tg-Gsp or Tg-TSHR* respectively. FRTL-5 cells were maintained in 6H and all other cells in 5H medium for 2 days. The FRTL-5 cells were then deprived of TSH (5H medium). After two more days, all cells were washed twice with 1.5 ml of KRH buer (140 mM NaCl, 5 mM Kcl, 2 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 6 mM glucose, 25 mM HEPES/NaOH pH 7.4) and incubated in 500 ml of KRH containing 0.4% bovine serum albumin, 0.5 mM IBMX, for 30 min at 378C in either the absence or the presence of 10 mU/ml TSH for FRTL-5 cells.
Reactions were stopped by aspiration of the medium followed by the addition of 500 ml ice-cold absolute ethanol. The number of cells in each well was determined by direct counting in a parallel plate. After overnight incubation at 7208C, cells were scraped in ethanol and the wells were rinced with 300 ml ice-cold absolute ethanol. The pooled 800 ml of extract were centrifugated for 10 min at 1500 g to remove cells debris and the supernatant dried under vacuum in a speed Vac. cAMP was measured by RIA (Rianen cAMP, DuPont/NEN).
Culture in soft agar
The bottom agar layer in 5 cm plates consisted of 6 ml of 6H or 5H medium containing 0.6% agar. Cells were suspended in 2 ml of top layer consisting of the same medium with 0.36% agar. After 4 weeks the plates were stained with 500 ml of nitroblue tetrazolium dye (0.4 mg/ ml) and X-phosphate (0.175 mg/ml) for 4 h at 378C. Macroscopic colonies were counted.
Tumorigenicity in nude mice 26 10 6 cells in 100 ml of PBS were injected in the¯ank of athymic female mice (4 ± 6 weeks old). The presence and the size of the tumors were scored 6 weeks after injection.
